Undifferentiated Carcinoma — Trials

Undifferentiated Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 15
Ph III recruiting: 3
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 151–162 of 162 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002852	Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer	completed	Phase 3	500	National Cancer Institute (NCI)NIH	1	Jul 3, 2013	clinicaltrials
NCT00040794	Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer	completed	Phase 2	144	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials